LBI-HTA - Publications - Search - Subject: QT 36-37 Biomedical engineering, nanotechnology, biocompatible materials
Number of items at this level: 13.

Breyer, E. (2007): [Nanotechnologies in medicine: Hopes and risks]. HTA-Newsletter 60: 2-3.

Eder, C. and Wild, C. (2019): Advanced Therapy Medicinal Products (ATMPs): Technology forecast. Journal of Market Access & Health Policy 7 (1).

Falkner, E. (2007): [Tissue engineering]. HTA-Newsletter 57: 3.

Falkner, E. and Eder, C. (2007): Health technology assessment: Evaluation of costs and benefits of therapies & methods. Int. J. Artif. Org. 2007. (In Press)

Falkner, E. and Eder, C. and Wild, C. (2007): Evaluation of regenerative medicine/tissue engineering approaches by health technolgy assessment. Regenerative Medicine 2007. (In Press)

Falkner, E. and Wild, C. (2008): Clinical application of Tissue Engineering: An overview of International and Austrian Areas of Research with a critical analysis of selected applications . LBI-HTA Projektbericht 013.

Goetz, G. and De Villiers, C. (2019): Allograft for anterior and posterior cruciate ligament reconstruction. Decision Support Document 116.

Künzl, M. and Wild, C. and Mathis, S. and Johansson, T. (2009): Autologous Chondrocyte Implantation. Systematic Review. Decision Support Document 34.

Wild, C. (2015): Biodegradable stents for the treatment of refractory or recurrent benign oesophageal stenoses. Decision Support Document 89.

Wild, C. (2012): Cell therapy for urinary stress incontinence. Decision Support Document 06 / Update 2012.

Wild, C. (2005): [Nanotechnology in medical research]. HTA-Newsletter 38: 3-4.

Wild, C. (2003): [Graftskin (Apligraf®) in the treatment of venous leg ulcers]. HTA-Newsletter 21: 3-4.

Wild, C. (1998): [Delphi-Austria: foresight on medical technologies and social-organisational developments in health care]. Delphi Report Austria 2.

This list was generated on Tue Sep 17 01:00:19 2019 CEST.